Prion pathogenesis is faithfully reproduced in cerebellar organotypic slice cultures by Falsig, Jeppe et al.
Zurich Open Repository and
Archive
University of Zurich
Main Library
Strickhofstrasse 39
CH-8057 Zurich
www.zora.uzh.ch
Year: 2012
Prion pathogenesis is faithfully reproduced in cerebellar organotypic slice
cultures
Falsig, Jeppe; Sonati, Tiziana; Herrmann, Uli S; Saban, Dino; Li, Bei; Arroyo, Karina; Ballmer, Boris;
Liberski, Pawel P; Aguzzi, Adriano
Abstract: Prions cause neurodegeneration in vivo, yet prion-infected cultured cells do not show cyto-
toxicity. This has hampered mechanistic studies of prion-induced neurodegeneration. Here we report
that prion-infected cultured organotypic cerebellar slices (COCS) experienced progressive spongiform
neurodegeneration closely reproducing prion disease, with three different prion strains giving rise to three
distinct patterns of prion protein deposition. Neurodegeneration did not occur when PrP was genetically
removed from neurons, and a comprehensive pharmacological screen indicated that neurodegeneration
was abrogated by compounds known to antagonize prion replication. Prion infection of COCS and mice
led to enhanced fodrin cleavage, suggesting the involvement of calpains or caspases in pathogenesis. Ac-
cordingly, neurotoxicity and fodrin cleavage were prevented by calpain inhibitors but not by caspase
inhibitors, whereas prion replication proceeded unimpeded. Hence calpain inhibition can uncouple prion
replication from its neurotoxic sequelae. These data validate COCS as a powerful model system that faith-
fully reproduces most morphological hallmarks of prion infections. The exquisite accessibility of COCS
to pharmacological manipulations was instrumental in recognizing the role of calpains in neurotoxicity,
and significantly extends the collection of tools necessary for rigorously dissecting prion pathogenesis.
DOI: 10.1371/journal.ppat.1002985
Posted at the Zurich Open Repository and Archive, University of Zurich
ZORA URL: http://doi.org/10.5167/uzh-67523
Published Version
 
 
Originally published at:
Falsig, Jeppe; Sonati, Tiziana; Herrmann, Uli S; Saban, Dino; Li, Bei; Arroyo, Karina; Ballmer, Boris;
Liberski, Pawel P; Aguzzi, Adriano (2012). Prion pathogenesis is faithfully reproduced in cerebellar
organotypic slice cultures. PLoS Pathogens, 8(11):e1002985. DOI: 10.1371/journal.ppat.1002985
Prion Pathogenesis Is Faithfully Reproduced in
Cerebellar Organotypic Slice Cultures
Jeppe Falsig1, Tiziana Sonati1, Uli S. Herrmann1, Dino Saban1, Bei Li1, Karina Arroyo1, Boris Ballmer1,
Pawel P. Liberski2, Adriano Aguzzi1*
1 Institute of Neuropathology, Zu¨rich, Switzerland, 2 Laboratory of Electron Microscopy and Neuropathology, Department of Molecular Pathology and Neuropathology,
Medical University of Lodz, Lodz, Poland
Abstract
Prions cause neurodegeneration in vivo, yet prion-infected cultured cells do not show cytotoxicity. This has hampered
mechanistic studies of prion-induced neurodegeneration. Here we report that prion-infected cultured organotypic
cerebellar slices (COCS) experienced progressive spongiform neurodegeneration closely reproducing prion disease, with
three different prion strains giving rise to three distinct patterns of prion protein deposition. Neurodegeneration did not
occur when PrP was genetically removed from neurons, and a comprehensive pharmacological screen indicated that
neurodegeneration was abrogated by compounds known to antagonize prion replication. Prion infection of COCS and mice
led to enhanced fodrin cleavage, suggesting the involvement of calpains or caspases in pathogenesis. Accordingly,
neurotoxicity and fodrin cleavage were prevented by calpain inhibitors but not by caspase inhibitors, whereas prion
replication proceeded unimpeded. Hence calpain inhibition can uncouple prion replication from its neurotoxic sequelae.
These data validate COCS as a powerful model system that faithfully reproduces most morphological hallmarks of prion
infections. The exquisite accessibility of COCS to pharmacological manipulations was instrumental in recognizing the role of
calpains in neurotoxicity, and significantly extends the collection of tools necessary for rigorously dissecting prion
pathogenesis.
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Introduction
Transmissible spongiform encephalopathies (TSE) are inexora-
bly fatal neurodegenerative disorders caused by prions [1] which
consist of PrPSc, a protease-resistant isoform of the normal cellular
prion protein PrPC. Accordingly, Prnpo/o mice lack PrPC, cannot
generate PrPSc, and withstand prion inoculation [2]. PrPSc forms
aggregates that grow by recruiting PrPC and whose breakage
underlies prion replication [3]. The hallmarks of TSEs include
PrPSc deposition and progressive brain damage. Prnpo/o mice show
mild phenotypes and no TSE [4–7], indicating that TSEs are not
caused by loss of PrPC function. Several observations suggest that
extracellular deposition of PrPSc is intrinsically innocuous [8–10],
whereas neurotoxicity is driven by unknown secondary triggers. A
mechanistic dissection of prion neurotoxicity necessitates faithful,
experimentally versatile in vitro models – yet such models have
proven difficult to generate [11,12].
COCS can be infected with various prion strains [13], with
prion titers peaking within 4 weeks. We reported that COCS
retain their normal cerebellar architecture and do not experience
prion-induced damage within a 1-month observational period.
We have now maintained intact organotypic morphology for
several months. Under these conditions we observed progressive
neurodegeneration starting 5 weeks post-inoculation in prion-
infected COCS.
Materials and Methods
Ethics statement
All mouse experiments for generation of prion isolates
conformed to Swiss law, were performed according to Swiss
federal guidelines (‘Ethical Principles and Guidelines for Exper-
iments on Animals’ 3rd edition, 2005) and were approved by the
Animal Experimentation Committee of the Canton of Zurich
(permit 200/2007). The specific experiments reported in this study
were mostly performed in primary cultures and cell lines and for
the most part substituted in vivo experiments with ex vivo
experiments.
Chemicals and mice
All compounds were purchased from Sigma-Aldrich unless
otherwise stated. GABAA-a6-cre mice were generated on a
C57BL/6xCBA background and intercrossed with Prnpo/o mice
[5,14]. Tg37 mice allowing for conditional PrP deletion was
generated on a Prnpo/o FVB background [15]. GABA-Aa6-CRE-;
loxPrP-tg37 littermates were used as negative controls (PrPCGC+).
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Prnpo/o and Prnpo/o;tga20+/+ (tga20), were on a mixed 129Sv/BL6
background [5,16]. Rocky Mountain Laboratory strain (RML;
passage #6) and 22L prions were amplified in CD1 mice, and
139A prions were amplified in C57BL/6 mice, by intracerebral
inoculation into the lateral forebrain of 30 ml 1% (wt/vol) brain
homogenate.
Organotypic brain culture preparation and prion
inoculation
Organotypic cerebellar slice cultures, 350 mm thick, were
prepared from 10–11 day-old pups according to a previously
published protocol [17]. Cultures were inoculated with 100 mg
brain homogenate per 10 slices. Brain homogenate was diluted in
2 ml physiological Gey’s balanced salt solution (GBSS) (NaCl
8 g l21, KCl 0.37 g l21, Na2HPO4 0.12 g l
21, CaCl2 2H2O
0.22 g l21, KH2PO4 0.09 g l
21, MgSO4 7H2O 0.07 g l
21, MgCl2
6H2O 0.210 g l
21, NaHCO3 0.227 g l
21) supplemented with the
glutamate receptor antagonist kynurenic acid (1 mM) (GBSSK).
Slices were incubated with infectious brain homogenates as free-
floating sections for 1 h at 4uC. Slices were then washed twice in
6 ml GBSSK, and 5–10 slices were placed on a 6-well Millicell-
CM Biopore PTFE membrane insert (Millipore). After removing
any residual buffer, inserts were transferred to a cell culture plate
and cultured in ‘‘slice-culture medium’’ (50% vol/vol MEM, 25%
vol/vol basal medium Eagle and 25% vol/vol horse serum
supplemented with 0.65% glucose (wt/vol), penicillin/streptomy-
cin and glutamax (Invitrogen)). Cultures were kept in a standard
cell incubator (37uC, 5% CO2, 95% humidity) and the culture
medium was exchanged three times weekly. Slices were harvested
for protein analyses or fixed for immunocytochemical analysis at
various time points.
Pharmacological treatment of COCS
Drug treatment was initiated 21 days post-inoculation (dpi) in all
cases. Drugs were re-added at every medium change. Appropriate
drug concentrations were determined by literature search, and we
assumed that slice culture uptake of compounds were similar to
other cell culture systems. The toxicity of each compound was
assessed by measuring NeuN immunoreactivity in parallel on
infected and non-infected slices; if toxicity occurred, drugs were
retested at a lower concentration. Drug and concentration used
were (2S,3S)-trans-epoxysuccinyl-L-leucylamido-3-methylbutane
ethyl ester (E64d, 15 mM, Bachem), z-Val-Phe-CHO (MDL-
28170, 50 mM), N-benzyloxycarbonyl-L-leucylnorleucinal (calpep-
tin, 100 mM), benzyloxycarbonyl-Asp-Glu-Val-Asp (OMe) fluor-
omethylketone (zDEVD-fmk, 20 mM), N-acetyl-L-a-aspartyl-L-a-
glutamyl-N-(2-carboxyl-1-formylethyl)-L-valinamide (Ac-DEVD-
CHO, 20 mM, Promega), benzyloxycarbonyl-Val-Ala-Asp (OMe)
fluoromethylketone (zVAD-fmk, 40 mM, R & D Systems). Drug
and concentration used for antiprion compounds were: pentosan
polysulphate (PPS, 300 ng ml21, kindly provided by Bene
pharmachem), quinacrine (1 mM), Congo red (1 mg ml21), am-
photericin B (4.5 mg ml21), suramin (50 mM), curcumin (1 mM),
cannabidiol (5 mM, Tocris), imatinib mesylate (10 mM, LC
Laboratories) and 2,6-dichlorobenzylideneaminoguanidine acetate
(guanabenz, 5 mM).
Misfolded Protein Assay (MPA)
Aggregated PrP was assessed using the Misfolded Protein Assay
[18,19]. Brain homogenate containing 5 mg protein was diluted in
1 ml TBS-T and subjected to affinity-based PrPSc enrichment
using magnetic beads coupled to the peptoid ASR-1 (KKKFKF).
Samples were incubated for 1 h at 37uC under permanent
agitation (750 rpm), washed, and digested with trypsin
(50 mg ml21 in 0.01 M CaCl2) for 30 min at 37uC (750 rpm)
[20]. Captured PrP was released and disaggregated by adding
75 ml of 0.1 N NaOH (10 min; 750 rpm). After neutralization
(30 ml 0.3 M Na2H2PO4, 5 min, 750 rpm), samples were placed
on a magnet to remove the beads, and 150 ml supernatant was
analyzed by a PrP ELISA by transferring the samples to POM19-
coated ELISA plates [21]. After 1 h incubation at 37uC (30 rpm),
plates were washed and POM2-AP was added (1 h, 37uC). After 3
washes, Lumiphos plus substrate (ECL, Amersham) was added,
incubated for 30 minutes at 37uC, and plates were read using a
chemiluminescence reader. All samples were analyzed at dilutions
falling within the logarithmic dose-response range of the calibra-
tion curves.
Quantification of PrPC expression by homogeneous-
phase Fo¨rster’s Resonance Energy Transfer (FRET)
A FRET based assay was established for the purpose of
quantifying FL-PrP expression in cerebellar slices. Europium
(Eu3+) donor and allophycocyanin (APC) acceptor fluorophores
were coupled to anti-PrP holoantibodies POM1 and POM2
recognizing the globular domain and the octarepeats, respectively.
The donor POM1-Eu3+ conjugate is excited at wavelength
340 nm and transfers energy to the acceptor conjugate POM2-
APC when the distance between acceptor and donor is ,10 nm.
POM2-APC then emits light at wavelength 665 nm, which can be
measured with a suitable time-resolving spectrofluorimeter. To
detect PrP level in homogenates, COCS were lysed; the Eu2+-
POM1 and APC-POM2 antibody pair was added, measured
immediately using a FRET reader and normalized to total protein.
Cerebellar slices were lysed in buffer containing 50 mM Tris-HCl
pH 8, 0.5% Na deoxycholate, and 0.5% Triton X-100.
Western blot analysis
COCS were washed twice in PBS. Cerebellar tissue was then
scraped off the membrane using 10 ml PBS per slice, and
homogenized by trituration using a 30 G syringe, followed by
2630 s pulses in a sonicator bath. Protein concentration was
determined using the bicinchoninic acid assay (Pierce). Samples
Author Summary
Transmissible spongiform encephalopathies (TSEs) are a
group of fatal protein misfolding diseases causing neuro-
degeneration in vivo. TSEs are unique in that the infectious
agent termed ‘prion’ consists of a misfolded protein
lacking sequence specific nucleic acids. Prion-infected
cultured cells do not develop visible pathological changes,
and this has hampered mechanistic studies of prion-
induced neurodegeneration. Here, we have developed a
prion-induced neurodegeneration model that uses cul-
tured slices of living brain tissue. Such slices display all the
classical hallmark of prion disease, namely prion replica-
tion, inflammation, spongiform changes and neurodegen-
eration. Neurotoxicity is blocked by anti-prion drugs by
reducing prion replication. We demonstrate for the first
time an involvement of calcium-regulated cysteine prote-
ases called calpains in driving neurotoxicity. We find that
the proteolytic processing of the calpain substrate is
induced by prion infection and blocked by calpain
inhibitors without prion replication being affected. The
assay system developed here allows for precise dissection
of the mechanisms of prion-induced degeneration with
pharmacological means.
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were adjusted to 20 mg protein in 20 ml and digested with
25 mg ml21 proteinase K in digestion buffer (0.5% wt/vol sodium
deoxycholate and 0.5% vol/vol Nonidet P-40 in PBS) for 30 min
at 37uC. This protocol allowed specific detection of PrPSc as
shown previously [13]. PK digestion was stopped by adding
loading buffer (NuPAGE, Invitrogen) and boiling samples at
95uC for 5 min. Proteins were separated on a 12% Bis-Tris
polyacrylamide gel or for higher molecular weight proteins on a
4–12% gradient gel (NuPAGE, Invitrogen) and blotted onto a
nitrocellulose membrane. Membranes were blocked with 5% wt/
vol Topblock (Fluka) in Tris-buffered saline supplemented with
Tween (150 mM NaCl, 10 mM Tris HCl, 0.05% Tween 20 (vol/
vol)) and incubated with primary antibodies in 1% Topblock.
Primary mouse monoclonal antibodies used were: POM1 mouse
IgG1 antibody raised against PrP
C (anti-PrPC) (200 ng ml21),
anti-a-fodrin (AA6, 100 ng ml21, Millipore), anti-GAPDH
(200 ng ml21, Millipore), and anti-actin (200 ng ml21, Chemi-
con). Secondary antibody used was horseradish peroxidase
(HRP)-conjugated rabbit anti–mouse IgG1 (1:10,000, Zymed).
Blots were developed using SuperSignal West Pico chemilumi-
nescent substrate (Pierce) and visualized using the VersaDoc
system (model 3000, Bio-Rad). COCS samples for fodrin blots
were harvested in PBS with 0.5% DOC, 0.5% NP-40 supple-
mented with 1 mM AEBSF and complete mini protease inhibitor
cocktail (Roche). Because of inefficiencies intrinsic to the tissue
slice homogenization procedure, some variation in loading
occurred and as a consequence all samples were normalized to
GAPDH as a loading control. In vivo samples for fodrin blots were
homogenized in PBS with 0.32 M sucrose supplemented with
1 mM AEBSF and ‘Complete mini’ protease-inhibitor mix. All
samples were normalized to alpha-tubulin. PNGase treatment
was performed using a commercially available kit, according to
the manufacturer’s protocol (New England Biolabs). In brief,
10 mg protein was treated with 2 ml denaturation buffer in a 20 ml
reaction and incubated for 15 min at 95uC. A reaction mixture of
2.6 ml G7, 2.6 ml NP-40 (10%), as well as 0.5 ml PNGase was
added and samples were incubated for 4 h at 37uC. Samples were
then mixed with loading dye, cooked and analyzed by western
blotting.
Histoblots and immunocytochemistry
Histoblot analysis was performed according to a standard
protocol using 50–100 mg ml21 PK (30 min, 37uC) [22]. Fresh
tissue sections were incubated on PVDF membranes soaked in
lysis buffer. After protein transfer, membranes were digested with
PK for 4 hours and PrPSc was detected with antibody POM1 to
PrP. The fluorescence Apoptag TUNEL assay was performed on
formalin fixed tissue sections according to the manufacturers
protocol (Millipore). For immunocytochemistry, the organotypic
slices were washed twice in PBS and fixed in 4% formalin
overnight at 4uC. Membrane inserts were washed and incubated
for 1 h in blocking buffer (0.05% vol/vol Triton X-100 and 3%
vol/vol goat serum dissolved in PBS) and incubated with primary
antibodies diluted in blocking buffer at 4uC for 3 d. Primary
antibodies and concentrations used were ascites fluid of mouse
anti–chicken calbindin IgG1 antibody (1:2,000, Swant), rabbit
anti-activated caspase 3 (1:300, BD Biosciences), rabbit anti-
human synaptophysin (1:300, Zymed), rat anti-MBP IgG2a
(1:700, Serotec) and mouse anti-Neuronal Nuclei (NeuN,
1 mg ml21, Millipore). The primary antibodies were detected
using Alexa-conjugated secondary antibodies (3 mg ml21, Molec-
ular Probes) and counterstained with 4,6-diamidino-2-phenylin-
dole (dapi) (1 mg ml21). For NeuN morphometry images were
recorded at 46 magnifications on a fluorescence microscope
(BX-61, Olympus) equipped with a cooled black/white CCD
camera and for caspase-3 stains on a Leica SP5 confocal laser
scanning microscope using a 636 oil immersion lens. NeuN
images were acquired at identical exposure times, and the area of
immunoreactivity was determined by morphometry with image
analysis software analySIS vs5.0 using identical grey-scale
threshold settings for identifying positive pixels. Histology was
performed on formalin-fixed, formic-acid decontaminated
COCS. Specifically, COCS were dehydrated and embedded in
paraffin with their membrane support. The paraffin blocks were
then turned by 90 degrees, re-embedded, and cut for conven-
tional histology.
Proteolysis assays
For caspase-3 activity determinations, slices were harvested in
pools (n=20) in PBS, 0.5% DOC, 0.5% NP-40 with 2% b-
mercaptoethanol and homogenized by trituration. Homogenates
were analyzed immediately for DEVDase activity using caspase 3
fluorometric detection kit (Assay design) and normalized to protein
concentration determined by Bradford assay.
Quantitative PCR
Organotypic slice cultures were prepared and incubated as
previously stated. Cultures were washed once with PBS and total
RNA was extracted using TRIzol reagent (Invitrogen Life
Technologies) according to the manufacturer’s protocol. Before
cDNA synthesis, residual genomic DNA was removed using the
DNA-free kit (Ambion); cDNA was synthesized from 1 mg total
RNA with the QuantiTect reverse transcription kit (Qiagen) using
random hexamers according to the manufacturer’s protocol. We
tested for successful cDNA synthesis (+reverse transcriptase) and
contamination of total RNA with genomic DNA (2reverse
transcriptase) by PCR with primers specific for b-actin (Actb).
Quantitative real-time PCR was performed using the SYBR
Green PCR Master Mix (Applied Biosystems) on an ABI PRISM
7700 Sequence detector (PerkinElmer). Regulation was calculated
relative to untreated wildtype slices after normalization to the Actb
signal. The following primer pairs were used: Actb sense, 59-GAC
GGC CAG GTC ATC ACT AT-39; antisense, 59-ACA TCT
GCT GGA AGG TGG AC-39. TNF sense, 59-CAT CTT CTC
AAA ATT CGA GTG ACA A-39; antisense, 59-TGG GAG TAG
ACA AGG TAC AAC CC-39. MCP-1 sense, 59-TTA AAA AAC
CTG GAT CGG AAC CAA-39; antisense, 59-GCA TTA GCT
TCA GAT TTA CGG GT-39. Rantes sense, 59-ATG CCG ATT
TTC CCA GGA CC-39; antisense, 59-TTT GCC TAC CTC
TCC CTA CTG-39.
Electron microscopy
Slices were washed in Na-phosphate buffer, fixed in freshly
prepared 2% PFA+2.5% GA in 0.1 M Na-phosphate buffer 0.1 M
pH 7.4, postfixed in osmium tetroxide, embedded in epon and
examined with transmission electron microscopes Jeol JEM 1011
and 100CX. Each sample grid was divided into 20 equally sized
‘‘grid squares’’ and the number of objects of interest (vacuoles,
dystrophic neurites and tubulovesicular structures) was determined
for each ‘‘grid square’’ covered by tissue.
Viability assay
For propidium iodide (PI) incorporation, slices were incubated
for 30 min with PI (5 mg ml21) and images were recorded in living
tissue using a fluorescent microscope (Axiovert 200) equipped with
a cooled CCD camera using a 56objective. Images were analyzed
by morphometry.
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Scrapie cell assay in endpoint format (SCEPA)
Prion-susceptible neuroblastoma cells (subclone N2aPK1) [23]
were exposed to 300-ml brain homogenates using 6–12 replicas
per dilution in 96-well plates for 3 d. Cells were subsequently
split three times 1:3 every 2 days, and three times 1:10 every 3 d.
After the cells reached confluence, 25’000 cells from each well
were filtered onto the membrane of ELISPOT plates, treated
with PK (0.5 mg ml21 for 90 min at 37uC), denatured, and
infected (PrPSc+) cells were detected by immunocytochemistry
using alkaline phosphatase-conjugated POM1 mouse anti-PrP
and an alkaline phosphatase-conjugated substrate kit (Bio-Rad).
We performed serial tenfold dilutions of experimental samples in
cell culture medium containing healthy mouse brain homoge-
nate. Scrapie-susceptible PK1 cells were then exposed to
dilutions of experimental samples ranging from 1024 to 1026
(corresponding to homogenate with a protein concentration of
10 mg ml21 to 0.1 mg ml21), or to a 10-fold dilution of RML or
healthy mouse brain homogenate. Samples were quantified in
endpoint format by counting positive wells according to
established methods [23].
Statistical analysis
One-way ANOVA with Tukey’s post-test for multi-column
comparison or a Dunnet’s post-test for comparison of all columns
to a control column were used for statistical analysis of
experiments involving the comparison of three or more samples.
Paired Student’s t-test was used for comparing two samples.
Results are displayed as the average of replicas 6 s.d.
Accession numbers
UniprotKB Reference Sequence: Beta-actin - P60710, Caspase-
3 - P70677, CD68 - P31996, Fodrin (aII-spectrin) - P16546,
GABAAa6 - P16305, GFAP - P03995, MBP - P04370, MCP-1 -
P10148, NeuN - Q8BIF2, PrP27-30 - P04925, Rantes - P30882,
TNF - P06804.
Results
In a first series of experiments, we confirmed our published
finding that Rocky Mountain Laboratory (RML) prions replicate
efficiently in COCS and, in addition, we found that infectivity
could be serially passaged by slice-to-slice transmission (Figure S1).
We then exposed wild-type (wt) COCS to RML, and maintained
them for 56 days post-inoculation (dpi). COCS exposed to
equivalent amounts of non-infectious brain homogenate (NBH)
maintained a stable density of NeuN+ cerebellar granule cells
(CGC) throughout the observational period (Figure 1A). In
contrast, the cerebellar granule layer (CGL) of prion-infected
cultures displayed progressive loss of synaptophysin and NeuN
(Figure 1A). Similarly, RML-treated PrPC-overexpressing tga20
[16] cultures showed a loss of CGL and calbindin+ Purkinje cells
(PC) at 42 dpi, whereas NBH treated slices maintained immuno-
histochemically intact CGL and PC (Figure S2A, D). Astrogliosis
seemed to be enhanced in prion-infected COCS as observed by
EM (Figure S2B), although this finding was partially obfuscated by
the high level of basal gliosis present in all COCS. TSE-typical
spongiform changes with a vacuole size of 2–5 mm, tubulovesicular
structures and dystrophic neurites all were exclusively present in
prion-infected wt (Figure 1B, Table 1) and tga20 cultures (Figure
S2C, S3A).
Tga20 COCS did not exhibit overtly altered GFAP+, MBP+,
and CD68+ cells (Figure 2A, S2A, D). Residual NeuN+ cells were
frequently associated with microglia, suggesting phagocytosis of
dying cells (Figure S2E). Hence the defining hallmarks of scrapie,
including selective neuronal loss, vacuolation and astrogliosis were
reproduced in prion-infected COCS.
Strain-specific effects of prion infection
We exposed COCS prepared from tga20 and Prnpo/o mice to
the three distinct prion strains, RML, 22L, and 139A. At 42 dpi,
PrPSc was detected in tga20 COCS exposed to each strain
(Figure 1C), but neither in Prnpo/o COCS nor in NBH-exposed
tga20 COCS, confirming that COCS are infectible with many
different prion strains, and that PrPSc reflected de novo synthesis
rather than residual inoculum. Similar results were obtained for wt
COCS at 56 dpi (Figure 1C), although the lower PrPC expression
resulted in lower PrPSc levels (Figure S2F).
Different prion strains induce distinct patterns of PrPSc
deposition and lesion profiles, and can differentially target distinct
neuronal subpopulations. Histoblots of COCS revealed strikingly
strain-specific PrPSc deposition patterns. RML induced a diffuse
signal akin to the ‘‘synaptic’’ pattern seen in vivo; 22L induced a
plaque-like pattern with dense, multifocal deposits; and 139A
induced ubiquitous PrPSc patches except in the central white
matter (Figure 1D). Prion-infected wt COCS at 42 dpi displayed
patterns equivalent to those found in tga20 COCS at 35 dpi. No
signal was seen in histoblots of prion-challenged Prnpo/o and NBH-
challenged tga20 COCS (Figure 1D).
RML infected tga20 COCS showed a selective loss of NeuN+
cells at 42 dpi (Figure 2A). NeuN+ cell loss was undetectable at
Figure 1. Localization and consequences of prion replication in COCS. (A) Fluorescence micrographs showing profound loss of NeuN+
cerebellar granule cells and of synaptophysin in wt COCS challenged with RML prions (56 dpi, right panel). No neuronal damage was detected in
COCS exposed to non-infectious brain homogenate (NBH; left panel). WM: white matter. ML: molecular layer. CGL: cerebellar granule cell layer. (B)
Electron microscopy showing membrane-enclosed intraneuronal spongiform vacuoles (left), tubulovesicular structures (PrP-deficient spheres
measuring between 20 and 40 nm in diameter, arrow, middle), and degenerating axons accumulating intra-cellular organelles including
mitochondria (arrow, right) in RML-infected wt slices at 56 dpi. (C) Immunoblots showing PrPSc in tga20 and wt, but not Prnpo/o COCS exposed to
prions (RML, 22L, 139A) or NBH. Sc; scrapie-sick wt mouse brain homogenate, used as positive control. (D) Histoblots showing strain-specific
differences in PrPSc deposition patterns of tga20 and wt COCS. No PrPSc signal was observed in Prnpo/o COCS and in PrP-expressing COCS exposed to
NBH.
doi:10.1371/journal.ppat.1002985.g001
Table 1. EM quantification of vacuoles and degenerating
neurites.
NBH RML 22L 139A
Grid squares
counted
325 211 121 177
Vacuoles 0 43 (15*) 36 (20*) 58 (15*)
Degenerating
neurites
0 48 15 41
Tubulovesicular
structures
not present present present present
*Number of myelinated vacuoles.
Grid size was 1225 mm2 and each grid square (61.25 mm2) contained a
maximum of one vacuole or degenerating neurite. A fraction of the vacuoles
were myelinated as indicated.
doi:10.1371/journal.ppat.1002985.t001
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28 dpi, and was absent from Prnpo/o COCS at 42 dpi, but was
conspicuous and significant in RML-infected COCS at 42 dpi
(Figure 2B). Therefore neurodegeneration was driven by prion
replication rather than by toxic inoculum constituents. The
severity of the spongiform changes was similar to that of cell loss:
RML, 22L, and 139A-infected wt COCS (56 dpi) displayed
vacuoles in 20, 30, and 33% of all EM grid squares respectively,
whereas no vacuolation occurred after NBH challenge (Table 1).
Many of these vacuoles were myelinated, consistent with
intraaxonal localization. RML, 22L, and 139A infected wt COCS
(56 dpi) displayed dystrophic neurites in 23, 12 and 21% of all grid
squares respectively, with no degenerating neurites observed in
NBH samples (Table 1). Tubulovesicular structures were sporad-
ically observed in all strains, but never in NBH samples (Table 1).
Selective ablation of PrP on cerebellar granule neurons (CGCs)
using GABAAa6-cre mice [14] intercrossed to PrP tg37 mice [15]
(PrPDCGC) resulted in abrogation of RML-induced loss of NeuN+
cells, showing that neuronal PrP confers neurotoxic signaling
(Figure 2C, S3B). Concomitantly with cell loss, a strong induction
of inflammatory cytokines TNFa, MCP-1, and Rantes was
observed at 6 weeks post-inoculation in RML tga20 cultures, but
not in RML-treated Prnpo/o COCS [5] (Figure 2D–E). Samples in
Figure 2D were normalized to tga20 NBH samples at 14 dpi and
samples in Figure 2E were normalized to NBH treated Prnpo/o
samples using the DDCt method. The inflammatory mediators
were found to be upregulated over NBH-exposed slices across 4
independent sets of samples analyzed by real-time PCR or
microarray analysis, each with 4 biological replicas per group
(data not shown).
Compounds conferring protection against prions
Several compounds reported to abrogate prions from infected
cell lines were tested on wt COCS for their ability to suppress
prion deposition. In order to study their potential to ameliorate
prion neurotoxicity, instead, we opted to use tga20 COCS because
they showed accelerated cell loss and smaller interslice variability.
In order to distinguish between interference with prion replication
and prevention of initial infection, drug treatment was initiated at
21 dpi (Figure 3A) when PrPSc accumulation was already
conspicuous [13]. At 35 dpi, before the appearance of neurotox-
icity, PrPC and PrPSc were measured in wt samples by Western
blotting (Figure 3B–C, S4A, n=2–3). In addition, we measured
protein aggregation by the misfolded protein assay (MPA), which
selectively captures PrP aggregates and upon a limited trypsin
digestion returns quantitative responses over a 4-log range [19]
(Figure 3D, S4B; n=4). Prion titers were determined by the
scrapie cell assay in end-point format (SCEPA; Figure 3D; n=3)
[23]. Finally, drug-treated tga20 COCS were maintained until
42 dpi and analyzed by NeuN morphometry (Figure 3E–F;
n=10). Neurotoxicity was defined as significant NeuN+ CGC loss
over NBH treatment, and neuroprotection was defined as
significant NeuN+ CGC rescue (p,0.05) over infected, untreated
COCS. By these criteria, pentosan polysulphate (PPS), ampho-
tericin B, Congo red, porphyrin, suramin, imatinib, and E64d
were neuroprotective, with several compounds completely pre-
venting cell loss (Figure 3E). No compounds were toxic to non-
infected cultures at the concentration used (Figure S4C).
We then studied the effects of each compound onto PrPSc
accumulation, PrP aggregation, and prion infectivity by quantita-
tive Western blotting after PK digestion, MPA, and SCEPA,
respectively. PPS, suramin, amphotericin B, guanabenz and
imatinib showed a strongest suppression of infectivity, PrP
aggregation, and PK resistance, whereas curcumin, cannabidiol
and quinacrine were ineffective (Figure 3C–D). In RML infected
drug treated COCS total PrP (PrPC+PrPSc) was only marginally
affected (Figure S4A). In uninfected cultures the amount of total
PrP was unaffected by drug treatment (Figure S4D; n=3). By
western blotting, suramin samples showed decreased FL-PrP and
E64d samples showed increased FL-PrP, suggesting that E64d
affects lysosomal degradation of PrP (Figure S4D). A significant
reduction in FL-PrP was observed only for suramin and
quinacrine treated cultures by FRET assay (Figure S4E; n=4),
suggesting that the anti-prion drug effects affected predominantly
PrPSc (Figure S4A). Surprisingly, Congo red increased PK
resistance while suppressing infectivity and aggregation
(Figure 3C–D). The dissociation of aggregation and PK resistance
from infectivity suggests that Congo red acts differentially on the
stability and frangibility of PrP aggregates, as previously described
for other amyloidotropic compounds in prion-infected COCS
[3,24]. In agreement with this notion, incubation of RML brain
homogenate with Congo red sufficed to confer increased PK-
resistance (Figure S4F), while relative aggregation was not
significantly affected (Figure S4G). Quinacrine, but no other
compound, also afforded partial neuroprotection against 3 mM
H2O2 (Figure S4H).
Calpains, but not caspases, mediate prion neurotoxicity
Prion-infected COCS displayed TUNEL+ (136653 vs. 19613
cells/mm2; p=0.0014; n=10, Figure S5A–B) and propidium-
iodide retaining (PI+) cells (Figure 4A–B; n=10), although to a
much smaller extent than staurosporine treated COCS (48 h;
.2000 TUNEL+ cells/field, Figure S5A–B). The progressive
increase in PI+ cells between 35–42 dpi correlated temporally with
NeuN+ cell loss (Figure 4A; n=10). Although there was some
variability between individual brain slices, all infected cultures
showed severe damage at later incubation times (Figure S6A–B).
PI+ cells were mostly confined to the CGL (asterisk), whereas
staurosporine induced rapid and widespread cell death also
affecting the CGL (Figure 4B). Hence prion-induced cell death
was mostly apoptotic, chronic-progressive rather than acute, and
preferentially targeting the CGL.
Whilst PPS, Congo red, and amphotericin B counteracted
neurotoxicity by inhibiting prion replication, E64d prevented
neurotoxicity, yet it did not reduce MPA readings, and enhanced
prion titers and PrPSc deposition (Figure 3E), suggesting that it
interfered with neurotoxic events downstream of prion replication.
Figure 2. Prion-induced neurodegeneration ex vivo. (A) COCS were stained with IgG1 antibodies to NeuN (green) and GFAP (red) and
counterstained with DAPI (blue). Representative images were recorded by confocal laser-scanning microscopy approximately 5 mm below the tissue
surface using a 406oil-immersion lens. Prion infection elicited severe NeuN+ cell loss. (B) Morphometric quantification of NeuN coverage in COCS
prepared from tga20 and Prnpo/o mice. The loss of NeuN immunoreactivity was progressive over time (left graph). No NeuN loss was seen in PrPC-
deficient COCS (right graph). Statistical shorthand here and henceforth: *: p,0.05; **: p,0.01; ***: p,0.001. (C) In contrast to control COCS (PrPCGC+),
COCS prepared from mice with conditional PrP-ablation in CGCs (PrPDCGC) showed no prion toxicity at 56 dpi. (D) Tga20 cultures exposed to NBH (2)
or RML (+) were analyzed at various time points by quantitative reverse-transcription PCR (qPCR) for Rantes, MCP-1 and TNFa. DCt values were
normalized to actin, with 1 being the ratio in uninfected cultures at 14 dpi6 s.d. Each data point is the average of 4 biological replicas. (E) Tga20 and
Prnpo/o cultures treated with NBH (2) or RML (+) were harvested at 42 dpi and analyzed by qPCR for Rantes, MCP-1 and TNFa. DCt values were
normalized to actin, with 1 being the ratio in untreated Prnpo/o COCS.
doi:10.1371/journal.ppat.1002985.g002
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Accordingly, E64d did not affect PrPSc glycosylation (Figure 4C),
total PrP expression and running pattern (Figure 4D), and PrP
processing into C1 and C2 fragments in prion-infected COCS,
although a reduction in full-length PrP was observed (Figure 4E, S7).
Because E64d inhibits cystein proteases including calpains, we
investigated a possible involvement of calpains in neurotoxicity.
Both calpains and caspases can cleave a-fodrin into a 150 kDa
fragment. In addition, calpains selectively generate a diagnostic
145 kDa fragment whereas caspases give rise to a 120 kDa
fragment [25]. Faint 145 kDa a-fodrin bands were barely apparent
in uninfected COCS, but displayed increased intensity upon prion
infection (n=3; p,0.01 at 37 dpi), peaking at 37–42 dpi on a
Figure 3. Anti-prion compounds. (A) Timeline of the pharmacological experiments in tga20 COCS. Drug treatments were initiated at 21 dpi and
re-added with each medium change (arrows). Longitudinal analyses revealed no cell loss at,35 dpi. Prion replication was assessed at 35 dpi, actively
ongoing cell death at 39–42 dpi (PI; fodrin; TUNEL) and severe neuronal loss at 42–45 dpi (NeuN). (B) Representative PrPSc immunoblots of wt COCS
challenged with RML prions (+) or NBH (2) and treated with compounds at 21–35 dpi. Blots were probed with POM1. (C) Total PrPSc (all PrPSc bands)
was quantified densitometrically and compared to untreated RML-infected COCS (grey). Red: compounds which were reported to interact with PrPC
or PrPSc. (D) Misfolded protein assay (upper panel) and scrapie cell assay (lower panel) of all wt samples from C. Relative aggregation and infectivity:
values were compared to untreated RML-infected COCS 6 s.d. (E–F) NeuN morphometry (lower panel) of tga20 slices exposed to RML or NBH and
treated with compounds from 21–42 dpi. All compounds reducing aggregation and/or infectivity were neuroprotective except guanabenz. In
contrast, E64d was neuroprotective although it enhanced prion infectivity. (F) NeuN staining showing CGL damage by RML infection (middle) and its
prevention by pentosan polysulphate (right).
doi:10.1371/journal.ppat.1002985.g003
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timescale consistent with increased PI incorporation (Figure 4A, F,
G). Therefore, enhanced a-fodrin cleavage generating the 145 kDa
fragment accompanies prion-induced neurodegeneration, suggest-
ing calpain activation. Fodrin cleavage was counteracted by
inhibiting prion replication with anti-prion compounds PPS, congo
red, and amphotericin B (Figure 4H–I; n=3; p,0.001) and was also
induced by a second prion strain, 22L (Figure 4J–K; n=4, p,0.05–
0.01). The 145 kDa fodrin cleavage product was also increased in
brains of terminally sick 22L infected tga20 mice and RML infected
wt mice, suggesting prion-induced calpain activation in vivo
(Figure 4L–M; n=3–5, p,0.01).
We then sought to dissect the relative contribution of calpain
and caspases to COCS neurotoxicity. Two further calpain
inhibitors, MDL-28170 and calpeptin, also significantly reduced
prion neurotoxicity (Figure 5A, S8A; n=9). Conversely, the
prevalence of cells containing activated caspase 3 (aC3) was similar
in uninfected vs. prion-infected COCS (79653 vs 139653 cells/
mm2; n=8; p.0.05), and enhanced by staurosporine treatment
(24 h; 6606295 cells/mm2; p,0.01; Figure 5B–C). Also, DEV-
Dase activity in COCS homogenates did not increase significantly
upon prion infection (Figure 5B; n=4, p.0.05). Crucially, the
caspase inhibitors z-DEVD-fmk and z-VAD-fmk antagonized
Figure 4. Temporal aspects of prion toxicity. (A–B) Tga20 slices were exposed to RML or NBH, cultured and scored for PI incorporation (red
bars) and NeuN+ morphometry (cyan dashed line) at 35, 37, 39, 42 and 45 dpi (RML; closed circles, NBH 45 dpi; open circle). The progressive
appearance of PI+ cells coincided with NeuN degradation, suggesting that dying cells were efficiently removed. Sts: staurosporine treatment (48 hrs,
5 mM). (B) Fluorescent images of PI-stained COCS (42 dpi). For better contrast, a non-linearly modified negative of the image is shown. PI+ cells are
mostly located in the CGL. (C–E) Treatment of tga20 RML cultures with tool compounds was initiated at 21 dpi. COCS were harvested at 39 dpi
(n=3). Homogenates were treated with PK (C), left untreated (D) or treated with PNGase (E), and Western blots were probed with POM1 to detect
PrPSc, total PrP, or total unglycosylated PrP (full-length and C1/C2 proteolytic fragments). The GAPDH band in panel E is representative for D, and
samples were loaded as in panel C. (F) Western blots of infected tga20 COCS (35–42 dpi; n=3) showing increased 145 kDa a-fodrin cleavage. (G)
Densitometric quantitation of a-fodrin cleavage fragments shown in panel F (ordinate: ratio of a-fodrin/GAPDH). a-Fodrin cleavage peaked at 37–
42 dpi. (H–I) Western blots (H) and densitometric analysis (I) of infected tga20 COCS treated with anti-prion compounds (21–40 dpi) showing
increasing 150/145 kDa a-fodrin cleavage in RML samples and reversal by anti-prion compounds. Densitometry readings were normalized against
GAPDH. (J–K) Western blots (J) and densitometric analysis (K) of NBH, RML and 22L treated tga20 COCS at 42 dpi, showing significantly increased
145 kDa a-fodrin cleavage in RML and 22L samples. Densitometry readings were normalized against GAPDH. (L–M) Western blots (L) and
densitometric analysis (M) of brain tissue from terminally sick 22L-infected tga20 mice and NBH-injected mice (left half of graph) or RML and NBH-
treated wt mice (right half), showing significantly increased 145 kDa a-fodrin cleavage in infected samples. The left panel of consist of two cropped
strips, cropped from the same blot at the same exposure. Densitometry readings were normalized against tubulin and normalized to NBH samples.
doi:10.1371/journal.ppat.1002985.g004
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staurosporine-induced toxicity (Figure S8B), yet neither compound
conferred antiprion neuroprotection (Figure 5D; n=10).
We then treated prion-infected COCS with protease inhibitors
starting at 21 dpi, and harvested samples at 41 dpi. The prion-
dependent increase in a-fodrin cleavage was reduced by E64d
(n=7, p,0.01), calpeptin and MDL-28170 treatment (n=3,
p,0.05–0.01), but not by caspase inhibition by z-DEVD-fmk
(Figure 5E–H; n=6, p.0.05). The above results imply that
calpains, rather than caspases, are causally involved in prion-
induced a-fodrin cleavage and neurotoxicity.
Discussion
Prion infection of COCS faithfully reproduced all salient
features of the pathogenesis of prion diseases: (1) progressive,
profound neuronal loss after a protracted asymptomatic incuba-
tion time (42 dpi in tga20 COCS), (2) a proinflammatory glial
response with vigorous upregulation of Rantes, MCP-1 and
TNFa, (3) typical neuropathological changes such as spongiform
changes, tubulovesicular structures, and neuroaxonal dystrophy,
and (4) an excessive meshwork of astrocytic processes exceeding
that observed in controls and reminiscent of gliosis. Conversely,
CGC loss in COCS was faster and stronger than in prion-infected
animals [26], suggesting that prion clearance may be less efficient
in COCS than in vivo.
Compounds suppressing prion replication and/or interacting
with PrPSc (PPS, CR, porphyrin, amphotericin B, imatinib and
suramin) were neuroprotective in the COCS-based screen,
whereas compounds previously reported to be effective in prion-
infected cell lines but not in vivo (quinacrine [27,28], curcumin
[29], and cannabidiol [30]) were ineffective despite the report of a
direct interaction of curcumin with PrPC (Table S1 in Text S1).
Hence inhibition of prion replication was neuroprotective to
COCS, and the COCS neurodegeneration assay predicted in vivo
efficacy more accurately than cell-based assays.
Not all drugs acted in a perfectly consistent manner in all assays
– a fact which reflects the biophysical and biological differences
between the variables measured by each assay. In particular,
Guanabenz treatment decreased prion infectivity, but failed to
show neuroprotection. This may reflect subliminal drug toxicity,
which indeed became evident after treatment of COCS with
higher concentrations of guanabenz (data not shown).
Congo red increased the protease resistance of PrP, yet it
decreased the capture of protein aggregates and prion infectivity.
This is consistent with results from cultures treated with other
amyloid-binding compounds [3,24] and probably indicates that
these compounds hinder prion replication by hyperstabilizing
protein aggregates. Indeed, congo red was reported to regulate the
stability of PrPSc aggregates [31] and we found that PK resistance
of PrPSc was enhanced by Congo red treatment. Suramin yielded
slightly higher MPA readings than what might have been expected
from PrPSc and infectivity determination, suggesting that it might
partially unfold prion fibrils and make them more available for
MPA capture. Porphyrin reduced PrPSc and MPA readings, and
was neuroprotective, yet it did not affect prion titers. These
discordant findings suggest that porphyrin may render PrPSc less
toxic without appreciably reducing prion replication.
E64d was neuroprotective to COCS despite slightly enhanced
PrPSc and infectivity accumulation, suggesting blockade of
neurotoxic pathways downstream of prion replication. E64d
inhibits preferentially cathepsins B, H, and L as well as calpains,
which participate to cell death [32] in excitotoxicity [33], brain
ischemia [34] and Alzheimer’s disease [35]. Further calpain
inhibitors (calpeptin and MDL-28170) were also neuroprotective
in vitro and all blocked the calpain-specific cleavage fragments of
the substrate fodrin. Instead of reducing prion replication or C2
cleavage [36], E64d enhanced prion accumulation in COCS,
possibly by inhibiting their lysosomal degradation.
Caspases can be cleaved by calpains [37], and prion-infected
brains can contain scattered caspase-3+ and TUNEL+ cells [38].
Although prion-infected COCS also harbored TUNEL+ cells, we
failed to detect any caspase activity, any activated caspase-3, and
any caspase-dependent a-fodrin cleavage. Crucially, two distinct
caspase inhibitors failed to confer neuroprotection. These data
suggest that prion neurotoxicity is calpain-dependent but caspase-
independent in CGCs. The prevalence of PI+ cells rose rapidly at
the time of onset of enhanced a-fodrin cleavage and was closely
followed by neuronal loss, suggesting that calpain-driven cell death
was quickly followed by lysis and removal.
Calpain activation strongly suggests that exaggerated calcium
influx may represent an important upstream event in pathogenesis.
We have attempted to test the latter hypothesis directly, but the
slow progression of prion pathology in COCS (which is similar to
that observed in vivo) posed significant obstacles. In particular, we
found that chronic treatment of COCS with Ca2+ chelators or
protracted culture in low-calcium medium was too toxic to allow
for any firm conclusion (data not shown).
We here identify calpain inhibition as an experimental
paradigm that uncouples prion replication from neurotoxicity.
While a few other examples of retarded neuropathogenesis despite
florid prion replication where reported earlier by us and others
[39,40], the molecular mechanism of such uncoupling had
remained unclear. The data presented here suggest that uncou-
pling occurs because calpain is a crucial link between prion-
induced intracellular hypercalcemia and cell death. It will be
exciting to test whether the chain of event hypothesized above may
be manipulated in order to control prion-induced damage rather
than prion replication.
Beyond the biological phenomena described above, a signif-
icant advance provided by this study consists - in our view - of
providing a convenient experimental paradigm that combines the
exquisite accessibility of in vitro systems with the rich palette of
neurotoxic and neurodegenerative events characteristic of prion
diseases, such as spongiform changes, neuronal loss, and
astrogliosis. The latter features could hitherto only be studied in
prion-infected experimental animals, since prion-infected cell
Figure 5. Calpain-mediated prion toxicity. (A) Treatment of RML infected tga20 COCS with three calpain inhibitors from 21–44 dpi significantly
antagonized neuronal loss in prion-infected tga20 COCS. Grey bars: untreated NBH (2) and RML (+) samples. (B, C) Tga20 cultures were harvested at
39 dpi and stained for activated caspase-3 (white bars) or homogenized and assayed for DEVDase activity (red bars). In contrast to staurosporine
treatment (STS; 24 h), prion infection did not significantly increase DEVDase and aC3+ cells. Average DEVDase activity in COCS (4 pools of 20 slices
each) normalized to the protein amount 6 s.d. (C) Representative images of B. (D) Tga20 slices were treated with z-DEVD-fmk or zVAD-fmk from 21–
44 dpi and analyzed by morphometric analysis. Grey bars: untreated. (E–F) Tga20 cultures were treated with calpain and caspase inhibitors from 21–
41 dpi, and probed for a-fodrin (n=6–7). GAPDH: loading control. (F) Densitometric quantification showing that a-fodrin cleavage was enhanced by
RML prion infection, and suppressed by E64d, but not by caspase inhibition (DEVD). (G–H) Tga20 cultures were treated with calpain inhibitors as in E,
and probed for a-fodrin (n= 3). GAPDH: loading control. (H) Densitometric quantification showing that a-fodrin cleavage was enhanced by RML prion
infection, and suppressed by MDL-28170 and calpeptin.
doi:10.1371/journal.ppat.1002985.g005
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lines do not exhibit significant cytotoxicity. The successful
transposition of prion-specific neurodegenerative features to
cultured tissues does away with many issues of pharmacokinetics,
bioavailability, and animal welfare, thereby enabling a broad
range of pharmacological experiments that had been hitherto
impractical or impossible. It is to be hoped that many laboratories
will make use of the technologies described here, and that
neurodegenerative prion science will consequently progress at a
faster pace.
Supporting Information
Figure S1 Tga20COCSwere infected with RML and harvested at
35 dpi (passage 1). COCS homogenate was re-transmitted into tga20
COCS at 10 mg ml21, equivalent to a titer of 1024, and harvest at
35 dpi (passage 2). Immunoblots of PrPSc in tga20 COCS show an
efficient prion replication at both the first and the second passage
through COCS. Sc; scrapie-sick wt mouse brain homogenate.
(EPS)
Figure S2 (A) Tga20 RML COCS were stained for calbindin
(green) and MBP (red) at 42 dpi. Images were recorded by
fluorescence (46 lens). (B) EM image of reactive astrogliosis in
RML-infected tga20 slices at 39 dpi. Reactive astrocytes are
characterized by prominent intermediate filament, giving the
appearance of intracellular lamellar structures (arrow). (C) Electron
microscopy showing membrane-enclosed intraneuronal spongiform
vacuoles (left), tubulovesicular structures (arrows, middle) and
degenerating axons accumulating intra-cellular organelles including
mitochondria (arrow, right) in RML-infected tga20 slices at 39 dpi.
(D–E) Tga20 slices were prepared as in (A), and stained for NeuN
(green), anti-CD68 (red), and optionally DAPI (blue). Images were
recorded by fluorescence (46 lens, D) or confocal microscopy (406
oil lens, F, 5 mm below the tissue surface). (F) Immunoblot of total
PrP (PrPC + PrPSc) from tga20, wt and Prnpo/o slices exposed to
prion-containing brain homogenates (RML, 22L or 139A) or NBH,
cultured for 42 (tga20) to 56 days (wt and Prnpo/o). Membranes were
probed with anti-PrP antibody POM1.
(EPS)
Figure S3 (A) Histology of NBH and RML treated tga20 COCS
at 42 dpi. H&E stainings identified vacuolation selectively in prion
infected tissue (arrow). (B) Representative images of Figure 2C.
COCS prepared from mice with conditional PrP-ablation in
CGCs (PrPDCGC) showed no prion toxicity at 56 dpi, while control
COCS (PrPCGC+) showed prion toxicity.
(EPS)
Figure S4 (A) Immunoblot of C57BL/6 COCS exposed to
RML-infected (RML) or uninfected (NBH) brain homogenate,
cultured for 21 days, treated with various compounds for 14 days,
and probed with antibody POM1 to PrP at 35 dpi. Leftmost lane:
brain homogenate of a terminally scrapie-sick wt mouse. (B)
Misfolded protein assay (MPA) of RML homogenate decadically
diluted in NBH, with or without trypsin digestion. Trypsin
digestion abolished NBH background signal, while retaining the
specific RML signal. (C) Morphometric assessment of NeuN+ area
in tga20 slices exposed to NBH (2) and treated with various
compounds for 21 days starting at 21 dpi. (D) Immunoblot and
morphometric analysis of C57BL/6 COCS exposed to uninfected
(NBH) brain homogenate, cultured for 21 days, treated with
various compounds for 14 days, and probed with antibody POM1
to PrP at 35 dpi. Results are presented as the ratio between PrPC
and actin, and data points were normalized to untreated samples.
(E) FRET analysis of FL-PrP expression in samples from D. (F)
RML brain homogenate (1 mg ml21) was incubated with different
concentrations of congo red for 1 h at 37uC, PK-digested, probed
for PrP and analyzed by morphometry. Treatment with Congo
red increased the amount of total PrP and the PK-resistance of
RML. (G) Samples from F were analyzed by MPA. No significant
changes were observed in Congo red-treated samples. (H) Tga20
cultures were kept for 14 days, pre-treated for 30 min with anti-
prion compound and then exposed to 3 mM H2O2 for 48 h.
Propidium iodide incorporation was assessed by morphometric
analysis and data are presented as the average PI+ area of 10 slices
6 s.d. Light grey bars: no treatment; dark grey: H2O2 followed by
no pharmacological treatment; red: treatment with anti-prion
compounds known to directly interact with PrP.
(EPS)
Figure S5 Tga20 slices were exposed to RML or NBH, cultured
and analyzed at 42 dpi by TUNEL assay and counterstained with
dapi. Sts: staurosporine treatment (48 hrs, 5 mM). (A) Representative
TUNEL images. (B) The number of TUNEL+ cells was counted and
RML treated samples showed increased TUNEL positivity com-
pared to NBH samples and substantially less than STS samples.
(EPS)
Figure S6 (A) Tga20 slices exposed to RML or NBH at 45 dpi
from Figure 4A. NeuN images represent the slice with the highest
and lowest NeuN value quantified in Figure 4A. (B) Images of
strongest and weakest PI-positive image from Figure 4A at 42 dpi.
(EPS)
Figure S7 Densitometric analysis of PrP band on Figure 4E,
normalized to GAPDH. RML infected COCS showed increased
density of C2 and decreased density of C1 fragments. While E64d
had no significant impact on C1 or C2 fragments, a small decrease
was observed in full length PrP.
(EPS)
Figure S8 (A) Tga20 slices were treated with calpain inhibitors
from 21–42 dpi and analyzed by NeuN morphometry. Uninfected
COCS showed no adverse effects of calpain inhibitor treatment.
(B) Staurosporine treatment of uninfected tga20 cultures treated
with caspase and calpain inhibitors. PI incorporation was assessed
after 48 h staurosporine treatment (1 mM) in the presence or
absence of drug treatment and analyzed by morphometry (n=9).
(EPS)
Text S1 This file contains Table S1, which shows the effects of
anti-prion compounds reported in this study. The ‘in vitro’ and ‘in
vivo’ columns describe the reported abilities of drugs to affect prion
replication in prion infected cell lines or mice respectively. ‘PrP
interaction’ indicates drugs that are thought to interact physically
with PrPC or PrPSc. Drugs were scored as ineffective (0), inhibitory
(+), or enhancing (2) for their effect on replication and
neuroprotection was scored as ineffective (0) or effective (+).
(DOC)
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